1-20 of 21
Yan-Rong Liu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dead/H-Box Helicase 11 ( DDX11 ) Mutations Correlate with Increased Relapse Risk in Persons with Acute Myeloid Leukaemia and Promote Proliferation and Survival of Human AML Cells in Vitro and in Immune Deficient Mice

Ya-Lan Zhou, MD, Li-Xin Wu, Robert Peter Gale, Zi-Long Wang, Jin-Lan Li, Hao Jiang, Qian Jiang, MD, Bin Jiang, Shan-Bo Cao, Ying Sun, Feng Lou, Chengcheng Wang, Yan-Rong Liu, Yu Wang, Ying-Jun Chang, Lanping Xu, Xiaohui Zhang, MD, Kaiyan Liu, Guorui Ruan, Xiaojun Huang, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2732.
DOI: https://doi.org/10.1182/blood-2019-127831
Published: 2019
Journal Articles

Genomic Landscape and Risk-Stratification for De Novo Acute Myeloid Leukemia with Normal Cytogenetics and No NPM1 or FLT3- itd Mutation

Ya-Lan Zhou, MD, Li-Xin Wu, Robert Peter Gale, Zi-Long Wang, Jin-Lan Li, Hao Jiang, Qian Jiang, MD, Bin Jiang, Shan-Bo Cao, Feng Lou, Ying Sun, Chengcheng Wang, Ting Li, Yan-Rong Liu, Yu Wang, Ying-Jun Chang, Lan-Ping Xu, Xiaohui Zhang, MD, Kaiyan Liu, Guorui Ruan, Xiaojun Huang, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1421.
DOI: https://doi.org/10.1182/blood-2019-127937
Published: 2019
Journal Articles

Osteoclast Stimulatory Transmembrane Protein ( OCSTAMP ) mRNA Levels and Clinical Variables in Persons with Plasma Cell Myeloma

Ya-Lan Zhou, MD, Jin Lu, Robert Peter Gale, Shen-Miao Yang, Li-Xin Wu, Jin-Lan Li, Ya-Zhen Qin, Yan-Rong Liu, Hao Jiang, Qian Jiang, MD, Xiaohui Zhang, MD, Lan-Ping Xu, Kai-Yan Liu, Xiao-Jun Huang, Guorui Ruan
Journal: Blood
Blood (2018) 132 (Supplement 1): 5264.
DOI: https://doi.org/10.1182/blood-2018-99-116883
Published: 2018
Journal Articles

Oral arsenic and all- trans retinoic acid for high-risk acute promyelocytic leukemia

Clinical Trials & Observations
Hong-Hu Zhu, Yan-Rong Liu, Jin-Song Jia, Ya-Zhen Qin, Xiao-Su Zhao, Yue-Yun Lai
Journal: Blood
Blood (2018) 131 (26): 2987–2989.
DOI: https://doi.org/10.1182/blood-2018-02-834051
Published: 2018
Includes: Supplemental data
Journal Articles

Mutation Topology of Adult B-Cell Acute Lymphoblastic Leukaemia

Li-Xin Wu, Run-Qing Lu, Kai-Yan Liu, Robert Peter Gale, MD ScD, PhD, Qi Zheng, Jiao Zhou, Jin-Lan Li, Shu-Juan Wang, Hao Jiang, MD, Qian Jiang, MD, Bin Jiang, Xiao-Hui Zhang, MD, Lan-Ping Xu, Yue Wang, Cheng-Li Song, Ya-Zhen Qin, Yan-Rong Liu, Xiao-Jun Huang, MD, Guo-Rui Ruan
Journal: Blood
Blood (2017) 130 (Supplement 1): 3986.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.3986.3986
Published: 2017
Journal Articles

Overexpression of Cysteine and Glycine-Rich Protein 2 in Bone Marrow As a Novel Biomarker in Adult B-Cell Acute Lymphoblastic Leukemia

Shu-Juan Wang, Wei-Min Wang, Wen-Yi Lu, Ya-Zhen Qin, Yue-Yun Lai, Yan-Rong Liu, Xiao-Jun Huang, Kai-Yan Liu, Guo-Rui Ruan
Journal: Blood
Blood (2016) 128 (22): 5271.
DOI: https://doi.org/10.1182/blood.V128.22.5271.5271
Published: 2016
Journal Articles

CD34 + CD38 - CD58 - leukemia-Propagating Cells at Diagnosis Could Identify Patients at High-Risk for Relapse in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Yuan Kong, MDPhD, Lan-Ping Xu, Yan-Rong Liu, Ya-Zhen Qin, Yu-Qian Sun, Yu Wang, Huan Chen, Hao Jiang, Qian Jiang, Ying-Jun Chang, PhD, Xiao-Jun Huang, MDPhD
Journal: Blood
Blood (2014) 124 (21): 3795.
DOI: https://doi.org/10.1182/blood.V124.21.3795.3795
Published: 2014
Journal Articles

Prevalence and Prognostic Significance of c-KIT Mutations in Core Binding Factor Acute Myeloid Leukemia: A Comprehensive Large-Scale Study from a Single Chinese Center

Ya-Zhen Qin, Honghu Zhu, Qian Jiang, Hao Jiang, Le-Ping Zhang, Jin-Lan Li, Ling-Di Li, Yan-Rong Liu, Yue-Yun Lai, Hong-Xia Shi, Bin Jiang, MD, Xiao-Jun Huang, MDPhD
Journal: Blood
Blood (2014) 124 (21): 1000.
DOI: https://doi.org/10.1182/blood.V124.21.1000.1000
Published: 2014
Journal Articles

In adults with t(8;21)AML, posttransplant RUNX1/RUNX1T1 -based MRD monitoring, rather than c-KIT mutations, allows further risk stratification

Clinical Trials & Observations
Yu Wang, De-Pei Wu, Qi-Fa Liu, Ya-Zhen Qin, Jing-Bo Wang, Lan-Ping Xu, Yan-Rong Liu, Hong-Hu Zhu, Jia Chen, Min Dai, Xiao-Jun Huang
Journal: Blood
Blood (2014) 124 (12): 1880–1886.
DOI: https://doi.org/10.1182/blood-2014-03-563403
Published: 2014
Journal Articles

Low WT1 Expression At Diagnosis Is a Strong Predictor On Poor Outcome In Patients With t(8;21) Acute Myeloid Leukemia

Ya-Zhen Qin, MS, Hong-Hu Zhu, MD, Qian Jiang, Dai-Hong Liu, MD, PhD, Hao Jiang, Lan-Ping Xu, MD, Huan Chen, Yu Wang, MD, Xiao-hui Zhang, MD, PhD, Jun-Yue Chai MM, Li-Ru Wang, MD, Yan-Rong Liu, MS, Xiao-Jun Huang, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1346.
DOI: https://doi.org/10.1182/blood.V122.21.1346.1346
Published: 2013
Journal Articles

CD34 + CD38 - CD58 - Candidate Leukemia-Initiating Cells Are Clinically Relevant With The Unfavorable Prognosis In Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Yuan kong, MD, PhD, Ying-Jun Chang, PhD, Yan-rong Liu, MD, Ya-zhe Wang, Qian Jiang, Hao Jiang, Ya-Zhen Qin, MS, Jing Wang, Hong-Hu Zhu, MD, Yue-Yun Lai, Lanping Xu, Dai-Hong Liu, MD, PhD, Xiao-Jun Huang, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 354.
DOI: https://doi.org/10.1182/blood.V122.21.354.354
Published: 2013
Journal Articles

MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial

Clinical Trials & Observations
Hong-Hu Zhu, Xiao-Hui Zhang, Ya-Zhen Qin, Dai-Hong Liu, Hao Jiang, Huan Chen, Qian Jiang, Lan-Ping Xu, Jin Lu, Wei Han, Li Bao, Yu Wang, Yu-Hong Chen, Jing-Zhi Wang, Feng-Rong Wang, Yue-Yun Lai, Jun-Yue Chai, Li-Ru Wang, Yan-Rong Liu, Kai-Yan Liu, Bin Jiang, Xiao-Jun Huang
Journal: Blood
Blood (2013) 121 (20): 4056–4062.
DOI: https://doi.org/10.1182/blood-2012-11-468348
Published: 2013
Includes: Supplemental data
Journal Articles

Prolonged Thrombocytopenia After Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) and Its Association with an Increase in CD8+ CX3CR1+ Cells in Bone Marrow.

Xiao-hui Zhang, MD, PhD, Guo-xiang Wang, MD, Yan-rong Liu, MD, Lan-Ping Xu, MD, Kai-Yan Liu, MD, Wei Han, MD, Yu Wang, MD, Hai-xia Fu, MD, Meng Lv, MD, Min Wang, MD, Yi Zhou, MD, Xiao-Jun Huang, MD
Journal: Blood
Blood (2012) 120 (21): 3077.
DOI: https://doi.org/10.1182/blood.V120.21.3077.3077
Published: 2012
Journal Articles

CD34 Expression On the Blasts of Bone Marrow Is a Novel Predictor of Poor Prognosis Independent of FlT3-ITD in Acute Myeloid Leukemia with NPM1-Mutation.

Hong-Hu Zhu, Yan-Rong Liu, Hao Jiang, Jin Lu, MD, Yazhen Qin, Qian Jiang, Xiaojun Huang
Journal: Blood
Blood (2012) 120 (21): 2491.
DOI: https://doi.org/10.1182/blood.V120.21.2491.2491
Published: 2012
Journal Articles

The PRAME and WT1 Transcripts Constitute a Good Molecular Marker Combination for Monitoring Minimal Residual Disease in Myelodysplastic Syndromes

Yazhen Qin, Honghu Zhu, PhD, Yan-rong Liu, MD, Ya-zhe Wang, Hong-Xia Shi, Yue-yun Lai, Lan-Ping Xu, MD, Daihong Liu, Xiaojun Huang
Journal: Blood
Blood (2012) 120 (21): 3853.
DOI: https://doi.org/10.1182/blood.V120.21.3853.3853
Published: 2012
Journal Articles

Risk stratification–directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation

Clinical Trials & Observations
Chen-Hua Yan, Dai-Hong Liu, Kai-Yan Liu, Lan-Ping Xu, Yan-Rong Liu, Huan Chen, Wei Han, Yu Wang, Ya-Zhen Qin, Xiao-Jun Huang
Journal: Blood
Blood (2012) 119 (14): 3256–3262.
DOI: https://doi.org/10.1182/blood-2011-09-380386
Published: 2012
Journal Articles

Imatinib Mesylate Is Superior to Allogeneic Hematopoietic Stem Cell Transplantation As the First-Line Therapy for Patients with Chronic Myeloid Leukemia in the Early Chronic Phase

Qian Jiang, Lan-Ping Xu, Dai-Hong Liu, Kai-Yan Liu, Bin Jiang, Xiao-hui Zhang, Yu Wang, Shan-Shan Chen, Xiao-Dong Mo, Xiang-Yu Zhao, Huan Chen, Yu-Hong Chen, Wei Han, Hao Jiang, Ya-Zhen Qin, Yan-Rong Liu, Yue-yun Lai, Hong-Xia Shi, Meng Lv, Xiao Jun Huang
Journal: Blood
Blood (2011) 118 (21): 162.
DOI: https://doi.org/10.1182/blood.V118.21.162.162
Published: 2011
Journal Articles

Leukemia Initiating Cells: New Markers for Minimal Residual Disease Monitoring in B-Precursor Acute Lymphoblastic Leukemia

Yuan Kong, MD, PhD, Yan-rong Liu, MD, Le Hao, Ya-zhe Wang, Kai-yan Liu, MD, PhD, Xiao-jun Huang, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2528.
DOI: https://doi.org/10.1182/blood.V118.21.2528.2528
Published: 2011
Journal Articles

Imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in the accelerated phase

Clinical Trials & Observations
Qian Jiang, Lan-Ping Xu, Dai-Hong Liu, Kai-Yan Liu, Shan-Shan Chen, Bin Jiang, Hao Jiang, Huan Chen, Yu-Hong Chen, Wei Han, Xiao-Hui Zhang, Yu Wang, Ya-Zhen Qin, Yan-Rong Liu, Yue-Yun Lai, Xiao-Jun Huang
Journal: Blood
Blood (2011) 117 (11): 3032–3040.
DOI: https://doi.org/10.1182/blood-2010-09-308510
Published: 2011
Journal Articles

Imatinib Mesylate Versus Allogeneic HSCT for Patients with Chronic Myelogenous Leukemia In Accelerated Phase: A Single Center Experience In China After a 9-Year Follow-up

Qian Jiang, Lan-Ping Xu, Dai-Hong Liu, Kaiyan Liu, MD, PhD, Shan-Shan Chen, Bin Jiang, MD, Hao Jiang, Huan Chen, Yu-Hong Chen, Wei Han, Xiao-hui Zhang, Yu Wang, Ya-Zhen Qin, Yan-Rong Liu, Yue-yun Lai, Xiao Jun Huang
Journal: Blood
Blood (2010) 116 (21): 2347.
DOI: https://doi.org/10.1182/blood.V116.21.2347.2347
Published: 2010